• / Free eNewsletters & Magazine
  • / My Account
Home>Research & Insights>Investment Insights>Don't Be Tempted by This ETF's Strong Performance

Related Content

  1. Videos
  2. Articles
  1. Do Industry Tilts Matter in Factor Investing?

    Investors buying funds that target factors like momentum or value should understand the impact industry tilts have had on performance, says Morningstar's Alex Bryan.

  2. Value Indexing With Less Price Risk

    Research Affiliates' John West says indexing based on fundamental factors, and not stock price, can help capture the value factor without buying the priciest securities.

  3. A Solid, Reasonably Priced Core Holding

    Bronze-rated T. Rowe Price Value has a diversified portfolio with a slight preference recently for healthcare and consumer-related stocks .

  4. Low Volatility vs High Dividend: Which One Is Better?

    Morningstar ETF Invest Conference panelists discuss the similarities, differences, and appeal of these two strategies in today's low-growth, low-return, and high-volatility market.

Don't Be Tempted by This ETF's Strong Performance

This fund's exchange focus and industry concentration dim some of its shine.

Alex Bryan, 04/28/2017

PowerShares QQQ ETF QQQ has established an impressive record. Over the trailing 10 years through March 2017, it outpaced the Russell 1000 Growth Index by 3.6 percentage points annualized, albeit with greater volatility. But a closer look reveals some critical shortcomings with the fund's underlying benchmark that limit its appeal. Most notably, the index has lopsided sector weightings, including a heavy stake in technology stocks, that it doesn’t explicitly target. These unintentional tilts are a source of risk. In addition, the index's focus on a single exchange (the Nasdaq) unnecessarily limits the stocks available to it. So, despite its strong record, modified market-cap-weighting approach, which promotes low turnover, and cost advantage against its actively managed peers, the fund earns a Morningstar Analyst Rating of Neutral.

The fund tracks the market-cap-weighted NASDAQ 100 Index, which includes the largest 100 nonfinancial stocks listed on the Nasdaq exchange. The Nasdaq is a tech-heavy exchange. Consequently, this sector soaks up over half of the fund’s assets and has a strong impact on performance. However, a pure tech sector fund would offer more efficient exposure to the sector. Concentration risk extends beyond this heavy technology weighting. Its top 10 holdings represent about half of the portfolio, exposing investors to some firm-specific risk.  

This strategy falls in the large-growth Morningstar Category, but its portfolio looks quite different from the category norm. Its exposure to the technology sector is more than twice as large as the Russell 1000 Growth Index’s, and it has less exposure to industrial, healthcare, and financial services stocks. In addition, because it limits its holdings to the largest nonfinancial stocks on the Nasdaq, it tends to have a larger market-cap orientation than the Russell benchmark.      

While the fund’s technology orientation won’t always pay off, it has worked out well over the past decade, owing to its overweighting in the technology sector and more favorable stock exposure in that sector. However, its sector concentrations tend to make it more volatile than most of its large growth peers. 

Fundamental View
The fund’s focus on the largest nonfinancial stocks on the Nasdaq gives it considerable exposure to multinational industry leaders, such as Apple AAPLAlphabet GOOGLMicrosoft MSFTAmazon.com AMZN, and Facebook FB. Most of its holdings generate attractive returns on invested capital and enjoy durable competitive advantages. However, there is no good rationale for limiting a portfolio to a single exchange, like the Nasdaq. This unnecessary constraint limits the stocks available to the fund. For example, it keeps some large technology stocks, like IBM IBMOracle ORCL, and Salesforce.com CRM (which are all listed on the New York Stock Exchange) out of the portfolio.

Market-cap weighting further pulls the portfolio toward the largest names on the Nasdaq, promotes low turnover, and reflects the market’s assessment about their relative value. Market prices (which drive market capitalization) should incorporate all publicly available information, so market-cap weighting is a solid approach. That said, this weighting approach increases the fund’s exposure to stocks as they become larger and more expensive, and reduces its exposure to stocks as they become smaller and cheaper, which may have higher expected returns. It also allows the market to dictate the composition of the portfolio and can increase concentration. While the portfolio includes around 100 stocks, about half of its assets are concentrated in the top 10 holdings. Apple alone represents more than 10% of the portfolio, but this weighting is actually less than Apple’s market-cap weight. The index adjusts the market-cap weightings of its holdings to ensure that the portfolio complies with IRS rules. This means that cumulative weighting of holdings that exceed 4.5% of the portfolio can’t exceed 48% and no more than 24% of the portfolio can be held in any single security.  

The fund’s fortunes are inexorably linked to those of the technology sector. Technology companies are usually less indebted than the broader equity market because they require less physical capital to operate. In addition, because the technology sector tends to evolve quickly, most technology companies reinvest most of their profits into research and development to fuel growth, rather than paying them out as dividends. Most of these firms trade at higher valuations than the broad market, reflecting their greater growth potential. However, if these firms fall short of the growth expectations embedded in their prices, they could underperform. There is no limit on the valuations the fund will pay for its holdings.

Consumer cyclical and healthcare stocks represent the fund’s next largest sector weightings at 17% and 11%, respectively, as of this writing. Consumer cyclical stocks tend to be more sensitive to market fluctuations (higher beta) than most, while healthcare stocks tend to be more defensive. In aggregate, the fund has tended to be more volatile and sensitive to market fluctuations than the Russell 1000 Growth Index over the trailing 10 years through March 2017. 

Portfolio Construction
Although it tracks a transparent index that weights its holdings by modified market capitalization (which keeps the portfolio compliant with IRS rules), the fund earns a Neutral Process Pillar rating. This is because it unnecessarily limits its holdings to the Nasdaq exchange and has large exposure to technology stocks that it doesn’t explicitly target, which is a source of risk.

The fund fully replicates the Nasdaq 100 Index, which includes the 100 largest nonfinancial stocks listed on the Nasdaq by market capitalization. Both U.S. and international stocks listed on the exchange are eligible, provided that the latter have options listed in the United States. That said, U.S. stocks currently account for about 95% of the portfolio. The index is reconstituted once a year in December. To reduce unnecessary turnover, the index allows existing constituents to stay in the index if they rank in the top 125 stocks by market capitalization and were in the top 100 at the previous review. Consequently, the fund may hold slightly more than 100 stocks. This is a tech-heavy index, as companies in this sector usually represent more than half of the portfolio. This fund is structured as a unit investment trust, which means it can’t use derivatives to equitize cash, reinvest dividends, or engage in securities lending.

Fees
The fund charges a 0.20% expense ratio, which is lower than most of its actively managed peers in the category, supporting the Positive Price Pillar rating. However, there are cheaper index alternatives. Over the trailing three years through March 2017, the fund lagged its index by 27 basis points annually, slightly more than the amount of its expense ratio, likely due to transaction costs. Full index replication has kept tracking error to a minimum.

Alternatives
Technology Select Sector SPDR ETF XLK (0.14% expense ratio) offers cleaner exposure to the technology sector. It invests in all technology stocks in the S&P 500, and does not limit its holdings to a particular exchange. This fund weights its holdings by market capitalization and earns a Bronze rating.

Vanguard Growth ETF VUG (0.08% expense ratio) offers broader exposure to large-growth stocks. It targets stocks representing the faster-growing half of the U.S. large-cap market and weights its holdings by market capitalization, resulting in more balanced sector allocations. This strategy carries a Silver rating.

A momentum fund, such as iShares Edge MSCI USA Momentum Factor MTUM (0.15% expense ratio), may also be a good alternative. Historically, relative performance has tended to persist in the short term. To take advantage of this effect, this fund targets stocks with the best recent risk-adjusted performance and weights its holdings according to both their relative momentum and market capitalization. However, it rebalances only twice a year. This fund earns a Silver rating. 

 

 

Disclosure: Morningstar, Inc. licenses indexes to financial institutions as the tracking indexes for investable products, such as exchange-traded funds, sponsored by the financial institution. The license fee for such use is paid by the sponsoring financial institution based mainly on the total assets of the investable product. Please click here for a list of investable products that track or have tracked a Morningstar index. Neither Morningstar, Inc. nor its investment management division markets, sells, or makes any representations regarding the advisability of investing in any investable product that tracks a Morningstar index.

 

Alex Bryan is an ETF analyst with Morningstar.

©2017 Morningstar Advisor. All right reserved.